Tech Center 1600 • Art Units: 1685
This examiner grants 52% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17765929 | STRESS ANALYSIS APPARATUS, STRESS ANALYSIS METHOD, AND COMPUTER-READABLE RECORDING MEDIUM | Final Rejection | NEC Corporation |
| 18067982 | Methods Of Identifying And Evaluating Liver Inflammation And Liver Fibrosis In A Subject By Determining A Stratified Score Based On Gene Expression | Non-Final OA | Regeneron Pharmaceuticals, Inc. |
| 16278611 | GAN-CNN FOR MHC PEPTIDE BINDING PREDICTION | Non-Final OA | REGENERON PHARMACEUTICALS, INC. |
| 19236435 | METHOD AND DEVICES FOR AGE DETERMINATION | Final Rejection | Thomas J.C. Matzen GmbH |
| 17283775 | METHOD AND DEVICES FOR AGE DETERMINATION | Non-Final OA | Thomas J.C. Matzen GMBH |
| 17510882 | PEPTIDE-BASED VACCINE GENERATION | Non-Final OA | NEC Laboratories America, Inc. |
| 17799621 | PANOMIC GENOMIC PREVALENCE SCORE | Non-Final OA | Caris MPI, Inc. |
| 17421653 | GENOMIC PROFILING SIMILARITY | Final Rejection | CARIS MPI, INC. |
| 18096868 | Estimation of Admixture Generation | Final Rejection | 23andMe, Inc. |
| 19077065 | DIFFUSION-BASED GENERATIVE AI METHODS FOR PROTEIN AND DRUG DESIGN | Non-Final OA | DEEP EIGENMATICS, INC. |
| 17608548 | SAMPLE ANALYSIS METHOD AND DEVICE BASED ON KERNEL MODULE IN GENOMIC MODULE NETWORK | Final Rejection | Industry-University Cooperation Foundation Hanyang University |
| 19040239 | PREDICTION METHOD AND PREDICTION SYSTEM FOR MRKH SYNDROM, AND DEVICE | Non-Final OA | PEKING UNION MEDICAL COLLEGE HOSPITAL, CHINESE ACAEMY OF MEDICAL SCIENCES |
| 17439900 | COMPUTER-IMPLEMENTED METHOD FOR COLLABORATIVE DEVELOPMENT OF REAGENTS FOR DETECTION OF TARGET NUCLEIC ACIDS | Non-Final OA | SEEGENE, INC. |
| 18089565 | IDENTIFICATION SYSTEM OF CIRCULATING BIOMARKERS FOR CANCER DETECTION, DEVELOPMENT METHOD OF CIRCULATING BIOMARKERS FOR CANCER DETECTION, CANCER DETECTION METHOD AND KIT | Non-Final OA | Industrial Technology Research Institute |
| 17304547 | TUMOR CLASSIFICATION BASED ON PREDICTED TUMOR MUTATIONAL BURDEN | Non-Final OA | Roche Sequencing Solutions, Inc. |
| 17804895 | METHOD AND SYSTEM FOR PREDICTING MUTATIONS IN RIBONUCLEIC ACID STRAINS | Non-Final OA | Wipro Limited |
| 17472899 | Artificial Intelligence Assisted Medical Diagnosis Method For Sepsis And System Thereof | Non-Final OA | China Medical University |
| 17859599 | MOLECULAR RESPONSE AND PROGRESSION DETECTION FROM CIRCULATING CELL FREE DNA | Final Rejection | Tempus Al, Inc |
| 17644339 | SYSTEM FOR PATHOGENICITY PREDICTION OF GENOMIC VARIANT USING KNOWLEDGE TRANSFER | Final Rejection | 3BILLION |
| 17617667 | METHOD FOR DETECTING GUT DYSBIOSIS OF INFANT | Non-Final OA | CJ Bioscience. Inc |
| 17766018 | Biomarker Panels for Guiding Dysregulated Host Response Therapy | Non-Final OA | Endpoint Health Inc. |
| 17629766 | METHODS OF IDENTIFYING DOPAMINERGIC NEURONS AND PROGENITOR CELLS | Non-Final OA | Aspen Neuroscience, Inc. |
| 17860169 | PET GENOME-BASED MATCHMAKING SOCIAL NETWORK SYSTEM AND METHOD FOR PROVIDING PET GENOME-BASED MATCHMAKING INFORMATION | Non-Final OA | CLINOMICS INC. |
| 17438462 | METHODS FOR DETECTING AND CHARACTERIZING MICROSATELLITE INSTABILITY WITH HIGH THROUGHPUT SEQUENCING | Non-Final OA | Sophia Genetics S.A. |
| 17629091 | A METHOD TO ASSIST IN THE EARLY DIAGNOSIS OF PANCREATIC ADENOCARCINOMA | Non-Final OA | UNIVERSITÀ CAMPUS BIO-MEDICO DI ROMA |
| 17556493 | LIFECYCLE ASSESSMENT SYSTEMS AND METHODS FOR DETERMINING EMISSIONS FROM ANIMAL PRODUCTION | Non-Final OA | Low Carbon Technologies, LLC |
| 17500766 | DIAGNOSTIC SYSTEM USING DIFFRACTION ANALYSIS OF IN VITRO SAMPLES | Non-Final OA | Arion Diagnostics, Inc. |
| 17497652 | METHODS AND SYSTEMS FOR THE DIAGNOSIS AND TREATMENT OF SEX HORMONE DISORDERS | Final Rejection | Function Promoting Therapies LLC |
| 17442840 | SYSTEMS AND METHODS FOR KARYOTYPING BY SEQUENCING | Final Rejection | PHASE GENOMICS, INC. |
| 17378404 | NEURAL NETWORK ARCHITECTURES FOR LINKING BIOLOGICAL SEQUENCE VARIANTS BASED ON MOLECULAR PHENOTYPE, AND SYSTEMS AND METHODS THEREFOR | Final Rejection | Deep Genomics Incorporated |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy